Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion type Assertion NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_head.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion wasGeneratedBy ECO_0000203 NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_provenance.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion wasDerivedFrom befree-2016 NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_provenance.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion SIO_000772 25088254 NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_provenance.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion evidence source_evidence_literature NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_provenance.
- NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_assertion description "[All-trans retinoic acid (atRA) treatment is the standard drug treatment for APL yielding cure rates > 80% by activating transcription and proteasomal degradation of retinoic acid receptor, alpha (RARα).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1207501.RAQG3ccBqMid9nAg89FS-3BNqDR9Lb_PKvmyMtDZ0dubs130_provenance.